Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-08
1993-02-02
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546100, A61K 31445
Patent
active
051838214
ABSTRACT:
N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide (amonafide) is an effective agent for the treatment of leukemias and solid tumors.
REFERENCES:
patent: 1796012 (1931-03-01), Eckert
patent: 2088978 (1963-05-01), Brunner et al.
patent: 3192263 (1965-06-01), Spiegler
patent: 3230259 (1966-01-01), Levy
patent: 4204063 (1980-05-01), Brana et al.
patent: 4499266 (1985-02-01), Cheng et al.
patent: 4594346 (1986-06-01), Zee-Cheng et al.
patent: 4665071 (1987-05-01), Zee-Cheng et al.
patent: 4714689 (1987-12-01), Stammann et al.
Fieser et al., "Reagents for Organic Synthesis", vol. 1, (1967), p. 440; John Wiley & Sons, N.Y.
Drug Res., vol. 34, pp. 1243-1246 (1984), Paull et al.
European J. of Med. Chem., vol. 16, pp. 207-212 (1981), Brana et al.
Revista Espanola de Oncologia, vol. 29, pp. 439-444 (1982), Stockert et al.
Alvarez-Ossorio Rafael P.
Berlanga Jose M. C.
Brana Miguel F.
De Gamboa Cristina R. F.
Garcia Jesus G.
Brust Joseph Paul
Laboratories Knoll, S.A.
LandOfFree
Method for treating leukemias using N-(2-dimethylaminoethyl)-3-a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating leukemias using N-(2-dimethylaminoethyl)-3-a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating leukemias using N-(2-dimethylaminoethyl)-3-a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-7040